Efficient Synthesis of 4-(3-Fluoro-5-{[4-(2-methyl-1H-imidazol-1-yl)benzyl]oxy}phenyl)tetrahydro-2H-pyran-4-carboxamide, a Novel 5-Lipoxygenase Inhibitor

Takashi Mano; Rodney W. Stevens; Kazunari Nakao; Yoshiyuki Okumura; Kiyoshi Kawamura; Akemi Ando; Yoko Matsuoka

doi:10.1055/s-2004-831227

PAPER

Efficient Synthesis of 4-(3-Fluoro-5-{[4-(2-methyl-1H-imidazol-1-yl)benzyl]oxy}phenyl)tetrahydro-2H-pyran-4-carboxamide, a Novel 5-Lipoxygenase Inhibitor

Takashi Mano*, Rodney W. Stevens, Kazunari Nakao, Yoshiyuki Okumura, Kiyoshi Kawamura, Akemi Ando, Yoko Matsuoka
Pfizer Global Research & Development, Nagoya Laboratories, 5-2 Taketoyo, Aichi 470-2393, Japan
Fax: +81(569)74 4748; e-Mail: Takashi.Mano@pfizer.com;

Abstract

All articles of this category

Abstract

An efficient synthesis of 1, a novel orally active 5-lipoxygenase inhibitor, was developed. Key features of the modified synthetic route include facile construction of the benzyl phenyl ether moiety by nucleophilic aromatic substitution and THP ring by cyclization, and base-promoted hydrolysis of the nitrile group to carboxamide. The improved three-step synthesis provides 25 g of 1 for pre-clinical toxicology studies in a total yield of 59%.

Key words

amides - cyclizations - drugs - nitriles - nucleophilic aromatic substitutions

Full Text

References

1a Samuelsson B. Science (Washington, D. C.) 1983, 220: 568

1b Lewis RA. Austen KF. Soberman RJ. New Engl. J. Med. 1990, 323: 645

2 Henderson WR. J. Allergy Clin. Immunol. 1987, 79: 543

3a Masamune H. Melvin LS. In Annual Reports in Medicinal Chemistry Vol. 24: Allen RC. Academic Press; San Diego: 1989. p.71-80

3b Jackson WT. Fleisch JH. In Progress in Drug Research Vol. 46: Jucker E. Birkhauser Verlag; Basel: 1996. p.115-168

4 Mano T. Stevens RW. Ando K. Nakao K. Okumura Y. Sakakibara M. Okumura T. Tamura T. Miyamoto K. Bioorg. Med. Chem. 2003, 13: 3879

5 Mano T. Miyamoto K. Okumura T. Okumura Y. Sakakibara M. Tamura T. Stevens RW. J. Med. Chem. 2004, 47: 720

6 Stevens RV. Lai JT. J. Org. Chem. 1972, 37: 2138

7 Fleming I. Loreto MA. Wallace IHM. Michael JP. J. Chem. Soc., Perkin Trans. 1 1986, 349

8 Eisleb O. Chem. Ber. 1941, 74B: 1433

9 Lambert-van der Brempt C. Bruneau P. Lamorlette M. Foster S. J. Med. Chem. 1994, 37: 113

10 Thompson D. Reeves P. J. Heterocycl. Chem. 1983, 20: 771

11 Kisel’ VM. Platonov MO. Kostyrko EO. Kovtunenko VR. Chem. Heterocycl. Compd. 2000, 36: 905

12a Robertson DW. Krushinski JH. Fuller RW. Leander JD. J. Med. Chem. 1988, 31: 1412

12b Martínez-Esparza J. Oficialdegui A.-M. Pérez-Silanes S. Heras B. Orús L. Palop J.-A. Lasheras B. Roca J. Mourelle M. Bosch A. Del Castillo J.-C. Tordera R. Del RoJ. Monge A. J. Med. Chem. 2001, 44: 418

13 Katritzky AR. Pilarski B. Urogdi L. Synthesis 1989, 949

14a Hall JH. Gisler M. J. Org. Chem. 1976, 41: 3769

14b Popov SA. Rukavishnikov AV. Tkachev AV. Synthesis 1992, 783

14c Felpin F.-X. Doris E. Wagner A. Valleix A. Rousseau B. Mioskowski C. J. Org. Chem. 2001, 66: 305

14d Engler TA. Furness K. Malhotra S. Sanchez-Martinez C. Shih C. Xie W. Zhu G. Zhou X. Conner S. Faul MM. Sullivan KA. Kolis SP. Brooks HB. Patel B. Schultz RM. DeHahn TB. Kirmani K. Spencer CD. Watkins SA. Considine EL. Dempsey JA. Ogg CA. Stamm NB. Anderson BD. Campbell RM. Vasudevan V. Lytle ML. Bioorg. Med. Chem. 2003, 13: 2261